<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004538A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004538</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13846900</doc-number><date>20130318</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="regional"><country>EP</country><doc-number>12305778.8</doc-number><date>20120629</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>G</section><class>01</class><subclass>N</subclass><main-group>33</main-group><subgroup>569</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>G</section><class>01</class><subclass>N</subclass><main-group>33</main-group><subgroup>56961</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>435  731</main-classification><further-classification>435  792</further-classification><further-classification>435  74</further-classification></classification-national><invention-title id="d0e61">METHOD FOR DIAGNOSING INVASIVE CANDIDA INFECTIONS</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="obligated-assignee"><addressbook><orgname>Bio-Rad Innovations</orgname><address><city>Marnes la Coquette</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="obligated-assignee"><addressbook><orgname>Universite Lille 2 Droit et Sante</orgname><address><city>Lille</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only" applicant-authority-category="obligated-assignee"><addressbook><orgname>Centre Hospitalier Universitaire de Lille</orgname><address><city>Lille</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>DAMIENS</last-name><first-name>Sebastien</first-name><address><city>Lille</city><country>FR</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>FRADIN</last-name><first-name>Chantal</first-name><address><city>Lille</city><country>FR</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>POULAIN</last-name><first-name>Daniel</first-name><address><city>Tampleuve</city><country>FR</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>SENDID</last-name><first-name>Boualem</first-name><address><city>Loos</city><country>FR</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>TABOURET</last-name><first-name>Marc Charles Victor</first-name><address><city>Ennetieres en Weppes</city><country>FR</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention concerns an in vitro method for diagnosing invasive candidiasis (IC) in a subject which comprises detecting the presence of a <i>Candida </i>glycan and detecting the presence of antibody directed against a protein selected from the group consisting of fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in a blood, plasma or serum sample of the subject. The invention also relates to a method of determining a suitable treatment regimen for a patient and to a kit for implanting the methods described herein.</p></abstract></us-patent-application>